Proactive Kidney Health

A formulation opportunity for proactive kidney and metabolic wellness.


Proactive kidney health

 

Kidney function declines gradually, and often without symptoms. Around 1 in 7 adults worldwide, some 788 million people, live with chronic kidney disease, and that number has more than doubled since 1990. Most are unaware until function is significantly reduced. Decline can begin as early as age 30 and is driven by common conditions such as diabetes, high blood pressure, and aging, together with the steady accumulation of gut-derived toxins.

 

Beyond feeling healthy

By the time kidney decline is felt, much may already have happened out of sight. For brands, growing interest in proactive, science-backed wellness creates an opportunity to develop daily nutrition concepts that support kidney and metabolic health before late-stage management becomes the focus. SynForU-ReMain offers a microbiome-first approach that works from the gut.

 

What the human evidence shows

This is not only theory; the gut-based approach is backed by human data. In a clinical study, kidney-transplant recipients with stable kidney function took the two-strain formula for three months and saw a significant improvement in their kidney-function markers (serum creatinine and eGFR), while a comparison group declined over the same period. The formula was well tolerated. It is an encouraging early sign of what daily, gut-based kidney support can do.

 

Consumer positioning opportunities

Three consumer positioning territories map naturally to SynForU-ReMain:

  • Proactive Agers: adults 30+ seeking proactive kidney and metabolic wellness before symptoms appear.
  • Metabolic Wellness Managers: consumers focused on blood sugar, blood pressure, weight, and related metabolic wellbeing.
  • Detox & Balance Seekers: wellness-oriented consumers drawn to gut-based internal balance and vitality.

 

Formulation opportunities

SynForU-ReMain can be incorporated into powders, stick packs, and capsules at around 10 billion CFU per day, giving brands flexibility across daily supplements and functional-food concepts, including convenient on-the-go formats.

SynForU-ReMain formulation formats

 

Bring proactive kidney health to your portfolio. Contact us for formulation support, samples, or the technical dossier.

 

Contact Us →

References

  1. GBD 2023 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10518):2461-2482. DOI: 10.1016/S0140-6736(25)01853-7
  2. Chan W-N, et al. A Pilot Study of Nephrogenic Probiotics to Further Improve an Already Stabilized Graft Function After Kidney Transplantation. Transplant Proc. 2023;55(9):2090-2094. DOI: 10.1016/j.transproceed.2023.08.011
  3. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States.
  4. National Kidney Foundation. About Chronic Kidney Disease.

This page is for B2B communication and education. Local regulations vary by country; customers are responsible for compliance before marketing or making health-related claims.